Companies › BBNX

BETA BIONICS INC (BBNX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001674632 · EDGAR filings · Updated 2026-07-24

BETA BIONICS INC (BBNX) has reported institutional ownership of 110.7%, with 130 institutional managers holding positions valued at $494.9M per the latest 13F reporting period.

Filings this week (1)

• 2026-07-24 — SCHEDULE 13G filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-02 — 4/A filed
• 2026-06-30 — Insider transaction reported (Form 4)
• 2026-06-29 — Notice of proposed sale filed (Form 144)
• 2026-06-26 — Notice of proposed sale filed (Form 144)
• 2026-06-25 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, BETA BIONICS INC has 130 institutional holders and institutional ownership of 110.7%.

Insider activity

Insiders reported 77 transactions (0 buys, 55 sells) across 11 reporting insiders, with a net reported value of −$3.16M.

Related companies

BRIDGEBIO ONCOLOGY THERAPEUTIC (BBOT) · COMPASS PATHWAYS ADR A FUNSPONSORED ADR 1 ADR REPS 1 ORD SHS (CMPS) · MAPLIGHT THERAPEUTICS INC (MPLT) · MINIMED GROUP INC (MMED) · SANA BIOTECHNOLOGY INC (SANA) · 4D MOLECULAR THERAPEUTICS IN (FDMT)